Access to anti-retroviral drugs, female in Bahamas
Bahamas: Access to anti-retroviral drugs, female was 76.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Bahamas, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Bahamas recorded 76.0% for access to anti-retroviral drugs, female in 2024.
Compared with earlier readings it is up 7.0% on the previous year and up 20.6% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Bahamas peaked at 78.0% in 2018 and was at its lowest, 0.0%, in 2000.
That places Bahamas 64th out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Bahamas, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 16.0% | — |
| 2004 | 21.0% | +31.2% |
| 2005 | 26.0% | +23.8% |
| 2006 | 38.0% | +46.2% |
| 2007 | 34.0% | -10.5% |
| 2008 | 49.0% | +44.1% |
| 2009 | 45.0% | -8.2% |
| 2010 | 35.0% | -22.2% |
| 2011 | 35.0% | +0.0% |
| 2012 | 45.0% | +28.6% |
| 2013 | 54.0% | +20.0% |
| 2014 | 63.0% | +16.7% |
| 2015 | 62.0% | -1.6% |
| 2016 | 59.0% | -4.8% |
| 2017 | 77.0% | +30.5% |
| 2018 | 78.0% | +1.3% |
| 2019 | 77.0% | -1.3% |
| 2020 | 75.0% | -2.6% |
| 2021 | 76.0% | +1.3% |
| 2022 | 74.0% | -2.6% |
| 2023 | 71.0% | -4.1% |
| 2024 | 76.0% | +7.0% |
Bahamas compared with similar countries
- Bahamas's 76.0% is below the median for high income countries, which is 82.0%, 93% of the median. (39 countries reporting)
- Bahamas's 76.0% is above the median for Latin America & Caribbean, which is 68.0%, 1.1× the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 22.9% | 0.0% | 49.0% | 10 |
| 2010s | 58.5% | 35.0% | 78.0% | 10 |
| 2020s | 74.4% | 71.0% | 76.0% | 5 |
Countries ranked near Bahamas
More gender data for Bahamas
- Child population (UN estimates and projections) 66.27 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.06 % change on previous year (2030)
- Population 344 (2030)
- Working-age population (UN estimates and projections) 344 (2030)
- Population (UN estimates and projections), annual growth rate 0.5945 % change on previous year (2030)
- Age population, age 00, female, interpolated 2,126 (2025)
- Age population, age 00, male, interpolated 2,179 (2025)
- Age population, age 01, female, interpolated 2,142 (2025)
- Age population, age 01, male, interpolated 2,194 (2025)
- Age population, age 02, female, interpolated 2,150 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Bahamas?
- Access to anti-retroviral drugs, female in Bahamas was 76.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Bahamas?
- The highest recorded value was 78.0% in 2018.
- What is the lowest access to anti-retroviral drugs, female recorded in Bahamas?
- The lowest recorded value was 0.0% in 2000.
- How does Bahamas rank for access to anti-retroviral drugs, female?
- Bahamas ranks 64th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Bahamas?
- Over the last ten years it is up 20.6%. The long-run trend across the full record is volatile.
- Where does this Bahamas data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.